ESR1 and breast carcinoma: A similar effect was also reported by a recent in vivo study (Andreani et al., 2017), which reported an induction of ERα+ breast cancer growth at low RES concentrations in Δ16HER2 mice receiving 4 μg RES daily for 15 weeks.